Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Fournier A., et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer, 2005; 114 (3):448–54.

Fowler R. E., et al.The progesterone content of rabbit uterine flushings. J. Reprod. Fert., 1977; 50:301–308.

Fraenkel L. Die Function des Corpus Luteum, Arch. f.Gyn, 1903; 68:438.

Franchimont P., et al. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids. Fertil. Steril., 1989; 52:1006–1011.

Franco H. L., et al. In vivo analysis of progesterone receptor action in the uterus during embryo implantation. Seminars in Cell & Developmental Biology, 2008; 19:178–186.

Frank R. T. The Ovary and the Endocrinologist. JAMA, 1922; 78:181.

Freedman D. S., et al. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics, 2002; 110:e43.

Freeman E. W. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology, 2003; 28:25–37.

Friedler S., et al. Luteal phase characteristics following GnRH antagonist or agonist treatment — a comparative study. Reprod. Biomed., Online, 2006; 12:27–32.

Friedman C. I., Kim M. H. Obesity and its effect on reproductive function. Clin. Obstet. Gynecol., 1985; 28:645–663.

Frisch R. E., Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science, 1970; 169:397–399.

Frisch R. E. Body fat, menarche, fi tness and fertility. Hum. Reprod., 1987; 2:521–533.

Frishman G. N., Hackett R. J., McGrath M., Metheny W. P. Evaluation of the prognosis of in vitro fertilization pregnancies with initially low serum human chorionic gonadotropin levels. Am. J. Obstet. Gynecol., 2001; 185:2392–2395.

Frobenius W. Ludwig Fraenkel: ’spiritus rector’ of the early progesterone research. Europ. J. Obstet. Gynecol. Reproduc. Biol., 1999; 83:115–119.

Frye C. A., Walf A. A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behavioral Neuroscience, 2004; 118:306–313.

Furukawa K., et al. Hormonal pregnancy tests and congenital malformation. Nature, 1967; 216:83.

Gallagher E. J. Application of likelihood ratios to clinical decision rules: defining the limits of clinical expertise. Ann. Emerg. Med., 1999; 34:664–667.

Gallaway M. S. The association between maternal use of spermicides, condoms, intra-uterine devices or progesterone and major structural birth defects. The University od Texas School of Public Health. Houston, 2008;139.

Gambrell Jr. R. D. Prevention of endometrial cancer with progestogens. Maturita, 1986;8:159–168.

Gann P. H., et al. The effects of a lowfat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study). Cancer, 2003; 98:1870–1879.

Garcia E., et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab., 1988; 67:80–87.

Garde R. V., Saner C. N., Price T. M. Discovery of a truncated progesterone receptor (PR-M) in the mitochondria; Plenary Oral Presentation, Wyeth Presidential Award, Society for Gynecological Investigation at the 53rd Annual Meeting; Toronto, Canada. March 2006.

Gardill B. R., et al. Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences. PLoS ONE, 2012; 7 (12):e52759.

Garn S. M., LaVelle M. Reproductive histories of low weight girls and women. Am. J. Clin. Nutr., 1983; 37:862–6.

Gaskins A. J., et al. Effect of daily fiber intake on reproductive function: the BioCycle Study1–3. Am. J. Clin. Nutr., 2009; 90:1061–1069.

Gauche´-Cazalis C., et al. Endometriosis and implantation: Myths and facts. Middle East Fertility Society Journal, 2012; 17:79–81.

Gavrilova-Jordan L. P., et al. Expression of a truncated progesterone receptor isoform (PR-M) in pregnant and laboring myometrium. Reprod. Sci., 2009; 16 (3 suppl):114A.

Gavrilova-Jordan L. P., et al. Expression of a truncated progesterone receptor (PR-M) correlates with mitochondrial content in human tissues. Reprod. Sci., 2009; 16 (3 suppl):189A.

Gelle P., Schaeffer P. Apropos of the use of dydrogesterone in gynecology and obstetrics; clinical experience. Bull. Fed. Soc. Gynecol. Obstet. Lang. Fr., 1965; 17:369–370.

Gellersen B., Brosens I. A., Brosens J. J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Sem. Reproduc. Med., 2007; 25:445–453.

Gellersen B., Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J. Endocrinol., 2003; 178:357–372.

Gellersen B., Fernandes M. S., Brosens J. J. Non-genomic progesterone actions in female reproduction. Human Reproduction Update, 2009; 15:119–138.

Gemmell R. T. A comparative study of the corpus luteum. Reprod. Fertil. Dev., 1995; 7:303–312.